NPI: 1629011234 · DEFIANCE, OH 43512 · General Acute Care Hospital · NPI assigned 06/13/2006
Authorized official RALSTON, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | RALSTON, KIMBERLY (VP REIMBURSEMENT) |
| NPI Enumeration Date | 06/13/2006 |
Other providers sharing the same authorized official: RALSTON, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 6,606 | $235K |
| 2019 | 6,303 | $231K |
| 2020 | 21,276 | $1.65M |
| 2021 | 31,436 | $2.24M |
| 2022 | 24,631 | $1.65M |
| 2023 | 85,747 | $3.47M |
| 2024 | 57,973 | $2.43M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 65,052 | 52,614 | $6.01M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 5,779 | 5,209 | $640K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 5,312 | 4,318 | $624K |
| 95813 | 984 | 904 | $548K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2,623 | 2,490 | $445K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2,692 | 2,098 | $335K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 4,416 | 1,449 | $330K |
| 96361 | Intravenous infusion, hydration; each additional hour | 764 | 446 | $229K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2,704 | 669 | $190K |
| 70450 | Computed tomography, head or brain; without contrast material | 835 | 651 | $181K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 724 | 543 | $178K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 617 | 469 | $150K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 834 | 485 | $139K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1,351 | 448 | $111K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 911 | 894 | $102K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 862 | 800 | $97K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 573 | 500 | $67K |
| 20610 | 447 | 325 | $66K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 348 | 289 | $66K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 524 | 390 | $59K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 536 | 479 | $55K |
| 80053 | Comprehensive metabolic panel | 6,932 | 5,405 | $51K |
| 90837 | Psychotherapy, 53 minutes with patient | 358 | 256 | $48K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 402 | 343 | $47K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 247 | 204 | $38K |
| 80061 | Lipid panel | 2,076 | 1,808 | $37K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 316 | 281 | $35K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 185 | 166 | $34K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1,761 | 1,441 | $32K |
| 36415 | Collection of venous blood by venipuncture | 17,463 | 14,021 | $32K |
| 84443 | Thyroid stimulating hormone (TSH) | 2,581 | 2,114 | $31K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 428 | 357 | $28K |
| 80048 | Basic metabolic panel (calcium, ionized) | 3,589 | 2,776 | $27K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,687 | 2,338 | $27K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 10,459 | 8,146 | $27K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,846 | 1,582 | $27K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,334 | 1,168 | $26K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 219 | 202 | $26K |
| 93886 | 121 | 112 | $23K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,076 | 905 | $22K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 223 | 188 | $22K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 204 | 200 | $22K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 270 | 65 | $21K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1,755 | 1,441 | $20K |
| G0008 | Administration of influenza virus vaccine | 975 | 914 | $18K |
| 97161 | 289 | 237 | $17K | |
| 71046 | Radiologic examination, chest; 2 views | 1,256 | 1,054 | $17K |
| 87428 | 1,497 | 1,268 | $17K | |
| 84439 | 849 | 715 | $16K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 99 | 96 | $16K |
| 95912 | 69 | 47 | $16K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 327 | 287 | $16K |
| 95957 | 490 | 477 | $16K | |
| 95886 | 182 | 144 | $16K | |
| 11721 | 626 | 586 | $16K | |
| 82607 | 980 | 863 | $14K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,612 | 1,316 | $13K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2,137 | 1,384 | $11K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1,610 | 1,532 | $11K |
| 11720 | 412 | 371 | $11K | |
| 92250 | 199 | 190 | $10K | |
| 93880 | 178 | 154 | $10K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 83 | 70 | $9K |
| 84702 | 556 | 397 | $9K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,583 | 1,328 | $9K |
| 90686 | 726 | 682 | $9K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4,189 | 3,066 | $9K |
| 73630 | 569 | 452 | $8K | |
| 76830 | Ultrasound, transvaginal | 206 | 171 | $8K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 81 | 79 | $8K |
| 93017 | 90 | 57 | $8K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 19 | 13 | $8K |
| 73562 | 387 | 318 | $7K | |
| 90670 | 648 | 638 | $7K | |
| 82746 | 833 | 732 | $7K | |
| 72100 | 276 | 206 | $7K | |
| 85027 | 1,561 | 1,222 | $7K | |
| 81001 | 3,977 | 3,223 | $6K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 17 | 14 | $6K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 587 | 505 | $5K |
| 64483 | 16 | 14 | $5K | |
| 90648 | 653 | 642 | $5K | |
| 87480 | 629 | 452 | $5K | |
| 92083 | 63 | 58 | $4K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 476 | 468 | $4K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 45 | 39 | $4K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 327 | 287 | $4K |
| 82728 | 322 | 269 | $4K | |
| 82570 | 520 | 446 | $4K | |
| G0009 | Administration of pneumococcal vaccine | 659 | 649 | $4K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2,835 | 1,244 | $4K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 21 | 21 | $4K |
| 87660 | 626 | 452 | $4K | |
| 86803 | 186 | 137 | $4K | |
| 86780 | 318 | 239 | $4K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,535 | 1,239 | $3K |
| 97597 | 40 | 12 | $3K | |
| 83540 | 415 | 355 | $3K | |
| 95819 | 29 | 21 | $3K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 252 | 180 | $3K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 221 | 176 | $3K |
| 93976 | 25 | 12 | $3K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 130 | 103 | $3K |
| 74018 | 55 | 41 | $3K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 30 | 14 | $3K |
| 73610 | 140 | 107 | $3K | |
| 87510 | 626 | 452 | $3K | |
| 81003 | 1,301 | 1,006 | $3K | |
| 86140 | 198 | 152 | $3K | |
| 73030 | 153 | 124 | $3K | |
| 85652 | 423 | 333 | $3K | |
| 80326 | 411 | 351 | $3K | |
| 83550 | 378 | 325 | $3K | |
| G0378 | Hospital observation service, per hour | 76 | 25 | $3K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 29 | 28 | $2K |
| 86900 | 95 | 59 | $2K | |
| 82043 | 403 | 344 | $2K | |
| 83735 | 907 | 658 | $2K | |
| 90723 | 364 | 358 | $2K | |
| 84484 | 2,630 | 1,586 | $2K | |
| 90715 | 135 | 115 | $2K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2,274 | 1,638 | $2K |
| 86225 | 103 | 83 | $2K | |
| 71045 | Radiologic examination, chest; single view | 1,344 | 1,084 | $2K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 43 | 40 | $2K |
| 85610 | 1,033 | 770 | $2K | |
| 71250 | 29 | 26 | $2K | |
| 87186 | 447 | 346 | $2K | |
| 80076 | 439 | 346 | $2K | |
| 73130 | 120 | 97 | $2K | |
| 86038 | 142 | 120 | $1K | |
| 90633 | 135 | 135 | $1K | |
| 90680 | 224 | 222 | $1K | |
| 86850 | 82 | 59 | $1K | |
| 83690 | 1,636 | 1,194 | $1K | |
| 81025 | 814 | 615 | $1K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 353 | 211 | $1K |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 129 | 107 | $1K |
| 76801 | 32 | 24 | $988.67 | |
| 84703 | 701 | 499 | $952.34 | |
| 87807 | 191 | 164 | $910.24 | |
| 80347 | 117 | 109 | $901.24 | |
| 0011A | 84 | 80 | $856.80 | |
| 96375 | Therapeutic injection; each additional sequential IV push | 1,620 | 1,055 | $750.42 |
| 82947 | 745 | 379 | $726.96 | |
| 85730 | 505 | 411 | $693.78 | |
| 86431 | 52 | 42 | $672.39 | |
| 87077 | 79 | 64 | $659.35 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 202 | 190 | $585.67 |
| 90656 | 70 | 68 | $571.93 | |
| 87340 | 65 | 40 | $535.93 | |
| 90710 | 96 | 94 | $493.35 | |
| 0012A | 63 | 63 | $474.00 | |
| 80355 | 118 | 110 | $452.13 | |
| 86901 | 94 | 59 | $410.31 | |
| 80320 | 53 | 43 | $400.02 | |
| 80364 | 116 | 108 | $392.89 | |
| 83037 | 26 | 26 | $336.68 | |
| 86147 | 49 | 25 | $333.22 | |
| 90674 | 16 | 15 | $298.76 | |
| 0031A | 15 | 14 | $288.80 | |
| 83880 | 228 | 172 | $249.28 | |
| 86762 | 19 | 12 | $243.32 | |
| 86787 | 18 | 13 | $218.82 | |
| 82565 | 19 | 12 | $210.37 | |
| 85379 | 502 | 375 | $187.68 | |
| 85651 | 55 | 53 | $185.85 | |
| 85018 | 23 | 14 | $131.78 | |
| 90661 | 20 | 20 | $129.82 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 2,212 | 1,438 | $129.67 |
| 83605 | 967 | 628 | $129.33 | |
| 87088 | 16 | 14 | $127.64 | |
| 87040 | 352 | 158 | $109.91 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 674 | 473 | $104.45 |
| 87205 | 19 | 12 | $103.91 | |
| 73110 | 27 | 25 | $84.05 | |
| 96376 | 184 | 106 | $67.31 | |
| J2704 | Injection, propofol, 10 mg | 1,404 | 767 | $62.55 |
| 82150 | 174 | 120 | $54.21 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 390 | 233 | $36.66 |
| 81002 | 14 | 12 | $36.28 | |
| 80143 | 31 | 25 | $34.87 | |
| 85613 | 26 | 25 | $23.36 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,023 | 1,477 | $19.26 |
| 80179 | 31 | 25 | $17.43 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,420 | 1,131 | $15.21 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 473 | 299 | $13.90 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1,807 | 1,171 | $9.77 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 242 | 174 | $9.30 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 104 | 38 | $8.38 |
| J0690 | Injection, cefazolin sodium, 500 mg | 36 | 25 | $4.38 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 211 | 131 | $1.61 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 62 | 50 | $0.97 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 1,107 | 930 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 115 | 77 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 16 | 12 | $0.00 |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 15 | 12 | $0.00 |
| 82248 | 20 | 17 | $0.00 | |
| 01936 | 44 | 38 | $0.00 | |
| 93892 | 56 | 56 | $0.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 22 | 13 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 17 | 14 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 29 | 14 | $0.00 |